Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Varchetta

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|March 21, 2012
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infectionStefania Varchetta, Dalila Mele, Stefania Mantovani, et al.
Journal of Hepatology|March 19, 2013
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infectionBarbara Oliviero, Dalila Mele, Elisabetta Degasperi, et al.
Oncotarget|November 24, 2015
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognitionMartina Di Modica, Lucia Sfondrini, Viola Regondi, et al.
Journal of Hepatology|December 15, 2010
Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infectionsBarbara Oliviero, Antonella Cerino, Stefania Varchetta, et al.
Retrovirology|December 17, 2013
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophagesStefania Varchetta, Paolo Lusso, Kelly Hudspeth, et al.
Journal of Medical Virology|April 3, 2024
Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccinationDalila Mele, Sabrina Ottolini, Andrea Lombardi, et al.
Cancer Research|December 20, 2007
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2Stefania Varchetta, Nadia Gibelli, Barbara Oliviero, et al.
Cellular & Molecular Immunology|October 16, 2020
Unique immunological profile in patients with COVID-19Stefania Varchetta, Dalila Mele, Barbara Oliviero, et al.
International Journal of Molecular Sciences|July 9, 2022
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 DonorsAlison Tarke, Marina Potesta, Stefania Varchetta, et al.
Frontiers in Immunology|December 3, 2021
High Frequencies of Functional Virus-Specific CD4<sup>+</sup> T Cells in SARS-CoV-2 Subjects With Olfactory and Taste DisordersDalila Mele, Anna Calastri, Eugenia Maiorano, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|March 21, 2012
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infectionStefania Varchetta, Dalila Mele, Stefania Mantovani, et al.
Journal of Hepatology|March 19, 2013
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infectionBarbara Oliviero, Dalila Mele, Elisabetta Degasperi, et al.
Oncotarget|November 24, 2015
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognitionMartina Di Modica, Lucia Sfondrini, Viola Regondi, et al.
Journal of Hepatology|December 15, 2010
Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infectionsBarbara Oliviero, Antonella Cerino, Stefania Varchetta, et al.
Retrovirology|December 17, 2013
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophagesStefania Varchetta, Paolo Lusso, Kelly Hudspeth, et al.
Journal of Medical Virology|April 3, 2024
Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccinationDalila Mele, Sabrina Ottolini, Andrea Lombardi, et al.
Cancer Research|December 20, 2007
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2Stefania Varchetta, Nadia Gibelli, Barbara Oliviero, et al.
Cellular & Molecular Immunology|October 16, 2020
Unique immunological profile in patients with COVID-19Stefania Varchetta, Dalila Mele, Barbara Oliviero, et al.
International Journal of Molecular Sciences|July 9, 2022
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 DonorsAlison Tarke, Marina Potesta, Stefania Varchetta, et al.
Frontiers in Immunology|December 3, 2021
High Frequencies of Functional Virus-Specific CD4<sup>+</sup> T Cells in SARS-CoV-2 Subjects With Olfactory and Taste DisordersDalila Mele, Anna Calastri, Eugenia Maiorano, et al.
Pageof 5